Supplement studies often fail to answer the questions they claim to address because the companies funding and running those studies have financial incentives to show their products work—and independent verification reveals what the original studies hide. When ConsumerLab tested 22 multivitamin supplements against their label claims, nearly one-third failed outright: vitamin A levels ranged as low as 11.8% of what was promised, while some products contained up to 4 times the claimed amounts of folate and zinc. These aren’t edge cases or unusual findings.
A systematic analysis of 272 herbal and dietary supplements found that 51% were mislabeled, with some pre-workout supplements containing anywhere from 59% to 176% of their claimed caffeine content. The reason independent verification matters so much for dementia care and brain health is simple: if you’re considering a supplement to support cognitive function or protect your brain, you need to know whether the product actually contains what the label says it does, whether the claimed benefits have been tested in independent studies (not funded by the manufacturer), and whether there are known risks the company hasn’t disclosed. Right now, that information gap is enormous. The FDA doesn’t test supplements before they reach store shelves, doesn’t verify that labels match contents, and doesn’t require companies to prove their products are safe or effective before sale.
Table of Contents
- HOW INDUSTRY FUNDING SKEWS SUPPLEMENT RESEARCH
- THE GAP BETWEEN LABELS AND WHAT’S ACTUALLY IN THE BOTTLE
- REGULATORY ABSENCE AND WHY IT MATTERS FOR BRAIN HEALTH
- HOW TO NAVIGATE CLAIMS WHEN INDEPENDENT VERIFICATION IS SCARCE
- THE REPLICATION CRISIS AND WHY MOST SUPPLEMENT STUDIES CAN’T BE TRUSTED
- ENFORCEMENT ACTIONS REVEAL HOW COMPANIES EXPLOIT REGULATORY GAPS
- NEW VERIFICATION STANDARDS AND WHAT THEY REQUIRE
- Frequently Asked Questions
HOW INDUSTRY FUNDING SKEWS SUPPLEMENT RESEARCH
Trials funded by manufacturers of supplements produce results that look dramatically better than trials with independent funding—and not because the supplements actually work better. Research published in the Journal of the International Society of Sports Nutrition in 2025 documented how industry-funded trials systematically show treatments as more efficacious and less harmful than non-industry-funded trials. The mechanisms behind this bias include selective reporting of favorable outcomes while downplaying or omitting unfavorable ones (called “spin”), choosing weak comparators that make the supplement look good by comparison, counting only the outcomes that support the company’s position, and p-hacking—running multiple analyses until one shows statistical significance. A single manufacturer can run dozens of small studies, publish only the positive ones, and create the illusion of robust evidence.
This matters because the brain health supplement market relies heavily on this kind of research to make claims. If you read that a compound “supports memory” or “promotes cognitive wellness,” there’s a high probability that claim originated in a study where the company selling the supplement paid for the work. Independent researchers testing the same compounds often get different results, but those results rarely make it into marketing materials or onto product labels. For someone with dementia or caring for someone with dementia, this means many supplements marketed for brain health have never been tested rigorously outside a laboratory or clinical trial funded by their manufacturer.
THE GAP BETWEEN LABELS AND WHAT’S ACTUALLY IN THE BOTTLE
What’s printed on a supplement label and what’s actually in the bottle are often two different things—and independent testing is the only way to know the difference. When ConsumerLab tested just eight nattokinase supplements (an enzyme people take for circulation and clotting concerns), 37.5% of them—three out of eight—contained less or more enzyme activity than their labels claimed. That’s a small sample, but it points to a systemic problem: there’s no consistent quality control, no pre-market verification, and no requirement that manufacturers prove their products match their labels. The problem extends far beyond nattokinase.
A 2025 analysis by Memorial Sloan Kettering Cancer Center examined 272 herbal and dietary supplement products and found that 51% were mislabeled. Pre-workout supplements, which often make claims about cognitive focus and energy, showed caffeine content ranging from just 59% of the labeled amount all the way up to 176% in some cases. For someone with dementia taking a supplement, this variability could mean taking significantly less of an active ingredient than expected, or—if the product is contaminated or overfilled—significantly more. Neither scenario is acceptable, yet both are common.
REGULATORY ABSENCE AND WHY IT MATTERS FOR BRAIN HEALTH
The FDA operates under a legal framework that treats dietary supplements very differently from medications, and this creates a dangerous gap in oversight. The FDA does not approve supplements before they’re sold to the public. It does not test them for safety or efficacy. It does not require companies to verify that what’s on the label matches what’s in the bottle. It does not verify shelf-life stability or consistency across batches.
Enforcement is purely reactive: the FDA only acts after problems are reported or discovered. For medications, the opposite is true—the burden is on the manufacturer to prove safety and efficacy before the drug reaches a patient. For supplements, there is no such burden. This regulatory difference is particularly concerning for brain health because cognitive decline is progressive and often irreversible. If someone with early-stage cognitive impairment takes a supplement that claims to support memory but contains 11.8% of its labeled active ingredient (as some multivitamins do), they’re not just wasting money—they’re potentially delaying the pursuit of treatments with actual evidence of benefit. Meanwhile, if another supplement in the same category contains 4 times the claimed amount of a nutrient, toxicity becomes a real concern, especially for people taking multiple supplements or medications that could interact with excess micronutrients.
HOW TO NAVIGATE CLAIMS WHEN INDEPENDENT VERIFICATION IS SCARCE
When supplement companies make claims about brain health or cognitive function, ask three questions before trusting the claim: Was the study funded by the company making the product or by an independent organization? Did the study test the finished product (the actual supplement you’d buy) or just an isolated compound in a lab? Has anyone else independently replicated the findings? If you can’t answer “independent,” “finished product,” and “yes” to all three, the evidence is weak. Independent verification doesn’t require expensive lab testing on your part—organizations like ConsumerLab and NSF International offer paid testing services for supplements, and they publish their results publicly so you can cross-reference your product.
Some supplement manufacturers voluntarily submit to third-party testing and display seals from these verifiers on their labels. These aren’t FDA approvals (nothing in supplements gets FDA approved), but they’re signals that the company is willing to stand behind label claims. The tradeoff is that verified supplements tend to cost more, and many people skip them because they assume all supplements are held to the same standard—which they absolutely are not.
THE REPLICATION CRISIS AND WHY MOST SUPPLEMENT STUDIES CAN’T BE TRUSTED
Even when a supplement study isn’t funded by a manufacturer, replication rates across nutritional science are alarmingly low. In 2025, researchers at Nature attempted to replicate 274 claims from social and behavioral sciences papers—the kind of research that often informs supplement recommendations. Only 55.1% of individual claims and 49.3% of papers showed statistically significant results that matched the original findings. Replication rates varied across disciplines from 42.5% to 63.1%, but in every case, roughly half the published results couldn’t be independently verified.
This means if you read five supplement studies touting cognitive benefits, odds are that at least two of them won’t hold up under independent testing. For people managing dementia or cognitive concerns, this creates a paralyzing situation: published research tells you one thing, but published attempts to replicate that research often fail. The failure isn’t always dramatic—sometimes a supplement shows a small positive effect in the original study but no effect in replication, or shows benefits only in subgroups (people of a certain age or genetic background) that don’t apply to you. The warning here is unavoidable: supplement research is inherently unreliable without independent replication, and most supplement studies have never been replicated at all.
ENFORCEMENT ACTIONS REVEAL HOW COMPANIES EXPLOIT REGULATORY GAPS
In April 2026, the FTC announced enforcement action against TruHeight, a height-growth supplement marketed with claims like “Help your child grow taller!” The company had posted glowing consumer reviews on its website and social media—but when the FTC investigated, it found that these “independent” testimonials were written by company employees, not by real customers. The supplement had no independent verification that it actually promoted growth in children. Just months earlier, in March 2025, the FDA and FTC issued coordinated warning letters to 10 companies marketing supplements with unproven claims to treat, cure, or prevent diabetes—disease claims that absolutely require independent, rigorous evidence but were being made without any.
The FTC has filed 120 cases over the last decade challenging health claims for supplements, and coordination between FTC and FDA remains active in 2026. But these cases are rare compared to the total number of supplement products on the market. When Golden Sunrise Nutraceutical was caught with deceptive marketing in January 2025, the FTC announced refunds—but most consumers never pursue refunds, and the damage (consumer trust wasted, potentially ineffective products used) is already done. Each enforcement case represents a company that got caught; most companies making dubious supplement claims simply don’t face regulatory scrutiny.
NEW VERIFICATION STANDARDS AND WHAT THEY REQUIRE
By 2026, a new tier of supplement verification has emerged, combining genetic, chemical, and spectral data to verify product identity and purity—a step far beyond what most supplements currently undergo. Both Health Canada and the FDA now require evidence that products retain their label-claimed strength throughout their full shelf life, not just at the moment of manufacture. Cal Laboratories and similar verification providers now test for contamination, potency degradation, and label accuracy using methods that can detect impurities as small as a few parts per million.
In March 2026, the FDA launched a unified Adverse Event Monitoring System (AEMS) that will track adverse reactions to dietary supplements—the first comprehensive federal system for catching harms associated with supplements. Companies now have just 15 business days to report serious adverse events to this system. For someone considering a supplement for brain health or dementia care, this new infrastructure means there’s finally a mechanism to detect if a product is causing neurological side effects, cognitive decline, or interactions with other medications. But the system only works if companies report honestly, and only helps if consumers monitor whether their supplement is in the adverse event database before taking it.
Frequently Asked Questions
How do I know if a supplement actually contains what the label says?
Look for third-party verification seals from organizations like ConsumerLab or NSF International on the product label. You can also visit their websites to see if your specific supplement has been tested independently. If a supplement has no verification seal and no independent testing record, the chances are high that the contents don’t match the label—51% of herbal and dietary supplements are mislabeled according to 2025 analysis.
What’s the difference between industry-funded and independent supplement studies?
Industry-funded studies are conducted or paid for by the company selling the supplement, which creates financial incentive to show the product works. They’re more likely to use selective reporting, weak comparators, and statistical p-hacking to generate favorable results. Independent studies are funded by universities, government agencies, or non-profit research organizations with no financial stake in the outcome. For brain health claims especially, you should prioritize independent research over industry studies.
If a supplement isn’t FDA-approved, is it automatically unsafe?
The FDA doesn’t approve any supplements—not because they’re all unsafe, but because supplements operate under a different regulatory framework than medications. That said, the FDA doesn’t test supplements for safety or efficacy before sale, doesn’t verify labels, and doesn’t require manufacturers to prove their claims. This is why third-party testing and independent research matter so much: they provide verification that the FDA legally cannot require.
Can a supplement contain toxic amounts of nutrients if it’s mislabeled?
Yes. Analysis of multivitamin supplements found some products contained up to 4 times the claimed amount of folate and zinc. For someone taking multiple supplements or certain medications, excess micronutrients can cause toxicity. Fat-soluble vitamins like A, D, E, and K accumulate in the body, and excess amounts can damage organs. If you’re taking supplements for brain or cognitive health, ask a healthcare provider whether your total intake (from food, supplements, and any medications) puts you at risk.
Why should I care about supplement verification if I’m managing dementia?
Cognitive decline is progressive and irreversible. If a supplement claims to support memory but contains only a fraction of its labeled active ingredient, you’re wasting time and money that could be spent on treatments with proven benefit. If a supplement is mislabeled or contaminated, it could interact with other medications or cause unexpected side effects. Independent verification ensures you’re actually getting what you paid for, and independent research tells you whether it’s worth taking at all.
